IMU University and AGTC Genomics Launch The First Pharmacogenomics Microcredential Programme in Malaysia to Advance Personalised Prescribing

Personalise treatment. Optimise drug response. Reduce preventable adverse reactions.

KUALA LUMPUR, 5 November 2026 — IMU University and AGTC Genomics have launched Malaysia’s first Pharmacogenomics Microcredential Programme, equipping healthcare professionals with practical skills to apply genetic insights to medication selection, dosing and clinical decision-making.

This pioneering initiative brings together IMU University’s expertise in healthcare education and AGTC Genomics’ experience in genomic testing to advance safer, more effective and patient-centred care.

Pharmacogenomics (PGx) examines how genetic differences influence an individual’s response to medicines. These differences can affect how quickly a drug is processed, whether it provides the intended benefit, and the likelihood of adverse reactions. By incorporating genetic information into prescribing decisions, healthcare professionals can better match medications and doses to individual patients.

As the first programme of its kind in Malaysia, this microcredential addresses the growing need to translate genomic knowledge into everyday clinical practice. Designed for clinicians, pharmacists and other healthcare professionals, the course bridges molecular principles with practical, real-world prescribing decisions.

Through structured modules, clinical case studies and applied exercises, participants will learn to interpret PGx test reports, use pharmacogenomic guidelines and decision-support resources, and assess evidence relevant to medication selection and dosing.

The programme also examines the clinical validity, cost-effectiveness, ethical considerations and health system challenges associated with PGx testing. This prepares participants to evaluate how pharmacogenomics can be integrated responsibly into their own healthcare settings, alongside patients’ medical histories, current medications and other clinical factors.

The collaboration reflects a shared commitment to extending the benefits of genomic testing through professional education. For AGTC Genomics, it represents an opportunity to contribute beyond laboratory services by strengthening the knowledge and confidence needed to apply genomic findings in patient care.

The course is delivered online over six weeks, with flexible, self-paced learning and an anytime start. Participants who complete all modules and assessments will receive an IMU-verified digital certificate.

By connecting academic expertise with practical genomic applications, IMU University and AGTC Genomics are helping build Malaysia’s capacity for precision prescribing—supporting more informed treatment decisions and better patient care.

Learn more and enrol: Pharmacogenomics Microcredential Programme

Course enquiries: icl@imu.edu.my